Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
CONMED Corporation is a medical devices business based in the US. CONMED Corporation shares (CNMD) are listed on the NYSE and all prices are listed in US Dollars. CONMED Corporation employs 3,300 staff and has a trailing 12-month revenue of around USD$874.5 million.
|Latest market close||USD$102.27|
|52-week range||USD$37.4668 - USD$114.3325|
|50-day moving average||USD$89.5511|
|200-day moving average||USD$81.618|
|Wall St. target price||USD$95.5|
|Dividend yield||USD$0.8 (0.76%)|
|Earnings per share (TTM)||USD$0.009|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||-2.08%|
|1 month (2020-11-06)||27.36%|
|3 months (2020-09-04)||19.61%|
|6 months (2020-06-05)||25.09%|
|1 year (2019-12-05)||-10.22%|
|2 years (2018-12-04)||52.66%|
|3 years (2017-12-05)||96.45%|
|5 years (2015-12-04)||139.90%|
Valuing CONMED Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CONMED Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CONMED Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11420x. In other words, CONMED Corporation shares trade at around 11420x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CONMED Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.29. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CONMED Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CONMED Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$143.5 million.
The EBITDA is a measure of a CONMED Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$874.5 million|
|Operating margin TTM||8.51%|
|Gross profit TTM||USD$528.9 million|
|Return on assets TTM||2.66%|
|Return on equity TTM||0.05%|
|Market capitalisation||USD$2.9 billion|
TTM: trailing 12 months
There are currently 846,967 CONMED Corporation shares held short by investors – that's known as CONMED Corporation's "short interest". This figure is 17.2% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting CONMED Corporation shares can be evaluated.
CONMED Corporation's "short interest ratio" (SIR) is the quantity of CONMED Corporation shares currently shorted divided by the average quantity of CONMED Corporation shares traded daily (recently around 174993.18181818). CONMED Corporation's SIR currently stands at 4.84. In other words for every 100,000 CONMED Corporation shares traded daily on the market, roughly 4840 shares are currently held short.
However CONMED Corporation's short interest can also be evaluated against the total number of CONMED Corporation shares, or, against the total number of tradable CONMED Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CONMED Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 CONMED Corporation shares in existence, roughly 50 shares are currently held short) or 0.0767% of the tradable shares (for every 100,000 tradable CONMED Corporation shares, roughly 77 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CONMED Corporation.
Find out more about how you can short CONMED Corporation stock.
Dividend payout ratio: 36.04% of net profits
Recently CONMED Corporation has paid out, on average, around 36.04% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.76% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CONMED Corporation shareholders could enjoy a 0.76% return on their shares, in the form of dividend payments. In CONMED Corporation's case, that would currently equate to about $0.8 per share.
While CONMED Corporation's payout ratio might seem fairly standard, it's worth remembering that CONMED Corporation may be investing much of the rest of its net profits in future growth.
CONMED Corporation's most recent dividend payout was on 5 January 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 December 2020 (the "ex-dividend date").
CONMED Corporation's shares were split on a 3:2 basis on 10 September 2001. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CONMED Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CONMED Corporation shares which in turn could have impacted CONMED Corporation's share price.
Over the last 12 months, CONMED Corporation's shares have ranged in value from as little as $37.4668 up to $114.3325. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CONMED Corporation's is 1.4019. This would suggest that CONMED Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
Everything we know about the Loha Co. IPO, plus information on how to buy in.
Everything we know about the Stem Inc IPO, plus information on how to buy in.
Everything we know about the View Inc IPO, plus information on how to buy in.
Everything we know about the Chime IPO, plus information on how to buy in.
Steps to owning and managing WPRT, with 24-hour and historical pricing before you buy.
Steps to owning and managing WBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing WLK, with 24-hour and historical pricing before you buy.
Steps to owning and managing WDC, with 24-hour and historical pricing before you buy.
Steps to owning and managing WAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing VSAT, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.